BSE - Corporate Announcement

Format of Initial Disclosure to be made by an entity identified as a Large Corporate.

Sr. No.	Particulars	Details
1	Name of Company	Concord Biotech Ltd
2	CIN NO.	U24230GJ1984PLC007440
3	Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr)	6.23
4	Highest Credit Rating during the previous FY	NA
4a	Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)	Not Applicable
5	Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the framework	NSE

We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No

Name of the Company Secretary: Prakash Sajnani
Designation: Asst Vice president Finance and CS
EmailId: finance@concordbiotech.com

Name of the Chief Financial Officer: Lalit Sethi
Designation: Chief Financial Officer
EmailId: lalitsethi@concordbiotech.com

Date: 25/04/2024

Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

Recently Viewed